Articles in the Bulletin have been unsigned since it began. This is because they aim to present a consensus view that incorporates contributions from many people, including specialists, general practitioners and members of the pharmaceutical industry, as well as the Bulletin’s Editorial Board and Advisory Council. We are very grateful to all contributors, but only have space to acknowledge those who have taken a major share in the production of articles published in the last year. We would like to thank by name.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.